From: An in silico analysis of rpoB mutations to affect Chlamydia trachomatis sensitivity to rifamycin
Author name | Study date | Reference | C. trachomatis strain | Antibiotic | Gene | Mutation | Accession number |
---|---|---|---|---|---|---|---|
Rupp et al. | 2007 | [20] | BU-434/L2 | Rifampin | rpoB gene | Q458K H471Y H471N | NC |
Suchland et al. | 2005 | [25] | BU-434/L2 | Rifampin | rpoB gene | I517M V466A H471L | NC |
Suchland et al. | 2005 | [25] | BU-434/L2 | Rifalazil | rpoB gene | I517M V466A H471L | NC |
Kutlin et al. | 2005 | [24] | UW-3/Cx/D | Rifampin and rifalazil | rpoB gene | H471Y | AY623623 |
Kutlin et al. | 2005 | [24] | BU-434/L2 | Rifalazil | rpoB gene | V136F | AY623623 |
Dresses-Werringloer et al. | 2003 | [21] | Serovar K | Rifampin | rpoB gene | A467T H471Y | NC |